Andrew Siderowf focuses on Psychiatry, Internal medicine, Disease, Parkinson's disease and Impulse control disorder. His Psychiatry study integrates concerns from other disciplines, such as Cronbach's alpha, Dementia and Audiology. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Placebo and Neurology.
His Disease study incorporates themes from Biomarker and Bioinformatics. His Parkinson's disease research incorporates themes from Physical therapy, Severity of illness and Rating scale. Andrew Siderowf interconnects Movement disorders, Punding and Dopamine dysregulation syndrome in the investigation of issues within Impulse control disorder.
Andrew Siderowf mainly focuses on Parkinson's disease, Disease, Internal medicine, Dementia and Psychiatry. His Parkinson's disease study combines topics in areas such as Central nervous system disease, Neuroscience, Depression, Gerontology and Physical therapy. His research in Physical therapy intersects with topics in Clinical trial and Rating scale.
His work deals with themes such as Pediatrics, Bioinformatics and Intensive care medicine, which intersect with Disease. His Internal medicine research includes themes of Gastroenterology and Oncology. His Psychiatry study combines topics in areas such as Movement disorders and Impulse control disorder.
His primary scientific interests are in Internal medicine, Parkinson's disease, Cohort, Disease and Dementia. His biological study spans a wide range of topics, including Gastroenterology and Oncology. Andrew Siderowf has researched Parkinson's disease in several fields, including Dopaminergic, Cerebrospinal fluid and Physical therapy.
His study in Cohort is interdisciplinary in nature, drawing from both Psychiatry, REM sleep behavior disorder, Montreal Cognitive Assessment and Hazard ratio. Andrew Siderowf specializes in Disease, namely Movement disorders. His Dementia research is multidisciplinary, incorporating perspectives in Alzheimer's disease, Cognition, Effects of sleep deprivation on cognitive performance and Audiology.
His scientific interests lie mostly in Internal medicine, Alzheimer's disease, Cohort, Cognition and Dopamine transporter. His Internal medicine research integrates issues from Positron emission tomography, Endocrinology and Oncology. His Cognition study incorporates themes from Dementia, Audiology and Pathology.
His Dopamine transporter research is multidisciplinary, incorporating elements of Cohort study, Psychiatry, Movement disorders and Parkinson's disease. His work focuses on many connections between Movement disorders and other disciplines, such as Rating scale, that overlap with his field of interest in Disease. His research is interdisciplinary, bridging the disciplines of Dopaminergic and Parkinson's disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins.
Movement Disorders (2008)
Projected number of people with parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey;R. Constantinescu;R. Constantinescu;J. P. Thompson;K. M. Biglan.
Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients
Daniel Weintraub;Juergen Koester;Marc N. Potenza;Andrew D. Siderowf.
JAMA Neurology (2010)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf.
Progress in Neurobiology (2011)
Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Daniel Weintraub;Andrew D. Siderowf;Marc N. Potenza;Joseph Goveas.
JAMA Neurology (2006)
A controlled trial of rasagiline in early Parkinson disease: The tempo study
Andrew Siderowf;Matthew Stern;Ira Shoulson;Karl Kieburtz.
JAMA Neurology (2002)
Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease
Daniel Weintraub;Staci Hoops;Judy A. Shea;Judy A. Shea;Kelly E. Lyons.
Movement Disorders (2009)
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
Hanae Nakashima-Yasuda;Kunihiro Uryu;John Robinson;Sharon X. Xie.
Acta Neuropathologica (2007)
Impulse control disorders in parkinson disease: A multicenter case–control study
Valerie Voon;Mandy Sohr;Anthony E. Lang;Marc N. Potenza.
Annals of Neurology (2011)
Montreal Cognitive Assessment Performance in Patients with Parkinson’s Disease with “Normal” Global Cognition According to Mini-Mental State Examination Score
Sarra Nazem;Andrew D. Siderowf;John E. Duda;Tom Ten Have.
Journal of the American Geriatrics Society (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: